Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Zalaegerszeg – page 8

115 clinical trials in Zalaegerszeg, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Zalaegerszeg at a glance
115
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

115 trials in Zalaegerszeg

Open in trial search
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.

Psoriatic arthropathy

Not recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Iodide
  • Sponsor:Faraday Pharmaceuticals Inc.
Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Opthea Limited

Breast cancer

Not recruiting
Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Cardiac failure acute

Not recruiting
Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin Propanediol Monohydrate
  • Sponsor:The Brigham And Women’s Hospital Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Oregovomab
  • Sponsor:Canariabio Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Boserolimab
  • Sponsor:Merck Sharp & Dohme LLC
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Acp-017
  • Sponsor:Ascendis Pharma Oncology Division A/S
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Hungary

The busiest research cities in the country

All 70 cities in Hungary

Clinical research in Zalaegerszeg

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on atherosclerotic cardiovascular disease and heart conditions. Studies evaluate new treatments for heart failure, stroke prevention, and post-heart attack recovery.

  • Heart Failure Management
  • Stroke Prevention
  • Cardiovascular Risk Reduction

Current trials are investigating medications for hypertrophic cardiomyopathy and post-stroke treatment options.

02 Oncology Studies

Comprehensive research into breast cancer treatments, particularly focusing on hormone receptor-positive and triple-negative variants. Studies evaluate novel therapeutic approaches.

  • Breast Cancer Therapies
  • Metastatic Disease Treatment
  • Targeted Drug Development

Multiple trials are exploring new treatment options for various stages of breast cancer.

03 Metabolic Disorders

Research initiatives examining treatments for Type 2 Diabetes and obesity. Studies focus on cardiovascular outcomes and weight management solutions.

  • Diabetes Management
  • Weight Control
  • Metabolic Health

Current studies evaluate innovative medications for improved metabolic control.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.